• Clinical and genetic characteristics of young children with epileptic encephalopathies and their role in the development of autism spectrum disorders
en To content Full text of article

Clinical and genetic characteristics of young children with epileptic encephalopathies and their role in the development of autism spectrum disorders

Modern Pediatrics. Ukraine. (2023). 4(132): 34-43. doi 10.15574/SP.2023.132.34
Kyrylova L. G.1, Miroshnikov O. O.1, Badyuk V. M.2, Dolenko O. O.2
1SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova NAMS of Ukraine», Kyiv
2«Ultragenom» LLC, Kyiv, Ukraine

For citation: Kyrylova LG, Miroshnikov OO, Badyuk VM, Dolenko OO. (2023). Clinical and genetic characteristics of young children with epileptic encephalopathies and their role in the development of autism spectrum disorders. Modern Pediatrics. Ukraine. 4(132): 34-43. doi 10.15574/SP.2023.132.34.
Article received: Jan 27, 2023. Accepted for publication: May 16, 2023.

Purpose – to analyze the clinical and genetic characteristics of young children with developmental and epileptic encephalopathies and to determine their role in the formation of autism spectrum disorders (ASD).
Materials and methods. The study included 58 children aged 0-3 years with the onset of epileptic seizures in the first year of life, clinical manifestations of developmental and epileptic encephalopathies with genetic etiology. The examination included assessment of neurological status, collection of anamnesis, assessment of semiology and determination of seizure type, assessment of development and screening for ASD at the age of 18 and 24 months, night sleep electroencephalography (video EEG), brain magnetic resonance imaging (MRI), screening for pathogenic variants by whole-exome sequencing or examination of relevant gene panels.
Pathogenic variants of 33 different genes were found in the examined children. Pathogenic variants of genes responsible for the function of ion channels (41.3%), intracellular signaling systems (17.2%), organelles and intracellular membranes (12.1%) were most frequently found. 44.8% of children had symptoms of ASD at the age of 18 months, and 68.9% of children at the age of 24 months.
The predominant types of epileptic seizures were myoclonic (37.9%) and focal clonic (34.4%). According to video EEG monitoring, interictal focal (39.6%) and multifocal (22.4%) epileptiform changes dominated in the examined children. According to MRI, structural changes of the brain were found in 86.2% of children.
Conclusions. It is shown that children with a history of myoclonic seizures (RR=1.264) and infantile spasms (RR=1.44) have a high risk of developing ASD at 24 months. It has been established that there is a positive relationship between the presence in the child of mutations in the genes responsible for the functioning of ion channels (RR=1.32), as well as for the functioning of synapses, neurotransmitters and receptors (RR=1.5) and the development of ASD in 24 months.
The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Bioethics and Deontology Commission. Informed consent of the children’s parents was obtained for the research.
No conflict of interests was declared by the authors.
Keywords: children, developmental epileptic encephalopathies, autism spectrum disorders, cognitive disorders, behavioral disorders, epileptic seizures, genetic mutations, sequencing of the next generation, electroencephalography, structural changes of the brain.

REFERENCES

1. Bartolini E. (2021). Inherited Developmental and Epileptic Encephalopathies. Neurology international. 13 (4): 555-568. https://doi.org/10.3390/neurolint13040055; PMid:34842787 PMCid:PMC8628919

2. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W et al. (2010). Revised terminology and concepts for organization of seizures and epilepsy: Report of the ILAE Commission on Classification and Terminology. Epilepsia. 51: 676-685. https://doi.org/10.1111/j.1528-1167.2010.02522.x; PMid:20196795

3. Blazekovic A, Jercic KG, Meglaj S, Duranovic V, Prpic I, Lozic B et al. (2022). Genetics of Pediatric Epilepsy: Next-Generation Sequencing in Clinical Practice. Genes. 13 (8): 1466. https://doi.org/10.3390/genes13081466; PMid:36011376 PMCid:PMC9407986

4. Chakraborty S, Parayil R, Mishra S, Nongthomba U, Clement JP. (2022). Epilepsy Characteristics in Neurodevelopmental Disorders: Research from Patient Cohorts and Animal Models Focusing on Autism Spectrum Disorder. International journal of molecular sciences. 23 (18): 10807. https://doi.org/10.3390/ijms231810807; PMid:36142719 PMCid:PMC9501968

5. Jehi L, Wyllie E, Devinsky O. (2015). Epileptic encephalopathies: Optimizing seizure control and developmental outcome. Epilepsia. 56: 1486-1489. https://doi.org/10.1111/epi.13107; PMid:26293588

6. Kim JB. (2014). Channelopathies. Korean journal of pediatrics. 57 (1): 1-18. https://doi.org/10.3345/kjp.2014.57.1.1; PMid:24578711 PMCid:PMC3935107

7. Kyrylova LH, Myroshnykov AA, Yuzva AA. (2021). Kohnytyvnaia dezyntehratsyia kak rasstroistvo neirorazvytyia detskoho vozrasta: klassyfykatsyia, dyahnostyka y vozmozhnosty terapyy. Pedyatryia. Vostochnaia Evropa. 9 (1): 63-78.

8. Kyrylova LH, Myroshnykov AA, Yuzva AA. (2021). Epyleptycheskye entsefalopatyy u detei s rasstroistvamy autystycheskoho spektra: ot molekuliarno-henetycheskoi dyahnostyky do tarhetnoi terapyy. Psykhyatryia, psykhoterapyia y klynycheskaia psykholohyia. 12 (2): 249-259.

9. Kyrylova LH, Yuzva OO, Myroshnykov OO. (2021). Klynyko-henetycheskye aspekti narushenyi razvytyia rechy, assotsyyrovannikh s epyleptycheskymy entsefalopatyiamy y rasstroistvamy autystycheskoho spektra u detei. Pedyatryia. Vostochnaia Evropa. 9 (3): 456-468. URL: https://www.elibrary.ru/item.asp?id=47079155.

10. McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS et al. (2022). Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA neurology. 79 (12): 1267-1276. https://doi.org/10.1001/jamaneurol.2022.3651; PMid:36315135 PMCid:PMC9623482

11. McTague A et al. (2016). The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 15 (3): 304-316. https://doi.org/10.1016/S1474-4422(15)00250-1; PMid:26597089

12. Nashabat M, Al Qahtani XS, Almakdob S, Altwaijri W, Ba-Armah DM, Hundallah K et al. (2019). The landscape of early infantile epileptic encephalopathy in a consanguineous population. Seizure. 69: 154-172. https://doi.org/10.1016/j.seizure.2019.04.018; PMid:31054490

13. Nieh SE, Sherr EH. (2014). Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics: the journal of the American Society for Experimental Neuro Therapeutics. 11 (4): 796-806. https://doi.org/10.1007/s13311-014-0301-2; PMid:25266964 PMCid:PMC4391391

14. Oyrer J, Maljevic S, Scheffer IE, Berkovic SF, Petrou S, Reid CA. (2018). Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies. Pharmacological reviews. 70 (1): 142-173. https://doi.org/10.1124/pr.117.014456; PMid:29263209 PMCid:PMC5738717

15. Raga S, Specchio N, Rheims S, Wilmshurst JM. (2021). Developmental and epileptic encephalopathies: recognition and approaches to care. Epileptic disorders: international epilepsy journal with videotape. 23 (1): 40-52. https://doi.org/10.1684/epd.2021.1244; PMid:33632673

16. Specchio N, Curatolo P. (2021). Developmental and epileptic encephalopathies: what we do and do not know. Brain: a journal of neurology. 144 (1): 32-43. https://doi.org/10.1093/brain/awaa371; PMid:33279965

17. Stafstrom CE, Kossoff EM. (2016). Epileptic Encephalopathy in Infants and Children. Epilepsy currents. 16 (4): 273-279. https://doi.org/10.5698/1535-7511-16.4.273; PMid:27582673 PMCid:PMC4988066

18. Vera-González A. (2022, Apr 2). Pathophysiological Mechanisms Underlying the Etiologies of Seizures and Epilepsy. In: Czuczwar SJ, editor. Epilepsy. Brisbane (AU): Exon Publications. Chapter 1. URL: https://www.ncbi.nlm.nih.gov/books/NBK580618/. https://doi.org/10.36255/exon-publications-epilepsy-pathopysiology